Pourroy, B.; Aumente, M.D.; Koenecke, C.; Stanulla, M.; Ferreri, A.J.M.; Murciano-Carillo, T.; Dandapani, M.; Ritzmann, T.A.; Barba, P.; Chatelut, E.;
et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124.
https://doi.org/10.3390/cancers18010124
AMA Style
Pourroy B, Aumente MD, Koenecke C, Stanulla M, Ferreri AJM, Murciano-Carillo T, Dandapani M, Ritzmann TA, Barba P, Chatelut E,
et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers. 2026; 18(1):124.
https://doi.org/10.3390/cancers18010124
Chicago/Turabian Style
Pourroy, Bertrand, Maria D. Aumente, Christian Koenecke, Martin Stanulla, Andrés J. M. Ferreri, Thais Murciano-Carillo, Madhumita Dandapani, Timothy A. Ritzmann, Pere Barba, Etienne Chatelut,
and et al. 2026. "High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry" Cancers 18, no. 1: 124.
https://doi.org/10.3390/cancers18010124
APA Style
Pourroy, B., Aumente, M. D., Koenecke, C., Stanulla, M., Ferreri, A. J. M., Murciano-Carillo, T., Dandapani, M., Ritzmann, T. A., Barba, P., Chatelut, E., Ingley, K. M., Morris, E., Schorb, E., Liebig, S., Schwartz, S., Howard, S. C., Combs, R., Tentoni, N., Lowe, J.,
... Rizzari, C.
(2026). High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers, 18(1), 124.
https://doi.org/10.3390/cancers18010124